Novartis' Trevor Mundel quits to join Gates Foundation
This article was originally published in Scrip
Effective from 1 December, Novartis' global head of development, Trevor Mundel, will leave the company to join the Bill and Melinda Gates Foundation as president of its Global Health Program. Mr Mundel has been a senior executive at Novartis since 2003. He is also on the boards of the Genomic Institute of the Novartis Research Foundation and the Novartis Venture Fund. Novartis plans to name a successor shortly.